Animal autogenous vaccines are used to treat various animal infections, including but not limited to dermatitis, sinusitis, otitis externa, pharyngitis, laryngitis and mastitis that may be induced by Gram-positive or Gram-negative bacteria, dermatophytes and yeasts.
This report contains market size and forecasts of Animal Autogenous Vaccines in global, including the following market information:
Global Animal Autogenous Vaccines Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Animal Autogenous Vaccines Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Animal Autogenous Vaccines companies in 2021 (%)
The global Animal Autogenous Vaccines market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Poultry Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Animal Autogenous Vaccines include Boehringer Ingelheim International, ZOETIS, Gallant Custom Laboratories, Ceva Biovac, Dyntec sro, UVAXX Pte Ltd, Deltamune Animal Health, Genova Labs and Hygieia Biological Laboratories, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Animal Autogenous Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Animal Autogenous Vaccines Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Animal Autogenous Vaccines Market Segment Percentages, by Type, 2021 (%)
Poultry
Pigs
Cattles
Fishes
Other
Global Animal Autogenous Vaccines Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Animal Autogenous Vaccines Market Segment Percentages, by Application, 2021 (%)
Large Farms
Family Farms
Global Animal Autogenous Vaccines Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Animal Autogenous Vaccines Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Animal Autogenous Vaccines revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Animal Autogenous Vaccines revenues share in global market, 2021 (%)
Key companies Animal Autogenous Vaccines sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Animal Autogenous Vaccines sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Boehringer Ingelheim International
ZOETIS
Gallant Custom Laboratories
Ceva Biovac
Dyntec sro
UVAXX Pte Ltd
Deltamune Animal Health
Genova Labs
Hygieia Biological Laboratories
Vaxxinova
Elanco Animal Health
Addison Biological Laboratory
Phibro Animal Health Corporation
Lohmann Tierzucht
RIPAC-LABOR GmbH
Aquatic Biologicals
Merck
BS-IMMUN GmbH
Ridgeway Biologicals